Description du livre Taschenbuch. Etat : Neu. Neuware -NATIONAL BESTSELLER The gripping story ofElizabeth Holmes and Theranos one of the biggest corporate frauds in history a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported bythe prize-winning journalist. With a new Afterword coveringher trial and sentencing, bringing the story to a close. Chilling . Reads like a thriller . Carreyrou tells [the Theranos story] virtually to perfection. The New YorkTimes Book ReviewIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: abrilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes s worth at an estimated $4.5 billion. There was just one problem: The technology didn t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings from journalists to their own employees. 438 pp. Englisch. N� de r�f. du vendeur 9780593081648

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 11,50

Autre devise

Ajouter au panier

Frais de port : EUR 23

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image fournie par le vendeur

Bad Blood

John Carreyrou

Edit� par Random House LLC US Jan 2020 (2020)

ISBN 10 : 0593081641 ISBN 13 : 9780593081648

Neuf Taschenbuch Quantit� disponible : 2

Vendeur :

Wegmann1855
(Zwiesel, Allemagne)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Taschenbuch. Etat : Neu. Neuware -The Financial Times & McKinsey Business Book of the Year A New York Times Notable Book A Washington Post Notable Book One of the Best Books of the Year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron-a tale of ambition and hubris set amid the bold promises of Silicon Valley. N� de r�f. du vendeur 9780593081648